SCHEMBL17825629

SCHEMBL17825629

NC(=O)c1ccc(C=O)cc1C=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.42
KDM4E B2RXH2 2/20 0.42
PTGS2 P35354 1/20 0.42
RAB9A P51151 1/20 0.42
PARP10 Q53GL7 1/20 0.42
PARP3 Q9Y6F1 1/20 0.42
ALDH1A1 P00352 6/20 0.38
TSHR P16473 1/20 0.38
UNG P13051 1/20 0.37
ALDH5A1 P51649 2/20 0.37
ABAT P80404 2/20 0.37
DGAT1 O75907 1/20 0.36
KMT2A Q03164 1/20 0.36
AOX1 Q06278 1/20 0.35
TRIM24 O15164 1/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TRIM33 Q9UPN9 1/20 0.35
PELI1 Q96FA3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11287843 0.85 KDM4E (0.39) ERN1KDM4EPTGS2RAB9APARP10
SCHEMBL30014296 0.82 ALDH1A1 (0.48) ERN1KDM4EPTGS2RAB9AALDH1A1
SCHEMBL436346 0.82 ALDH1A1 (0.48) ERN1KDM4EPTGS2RAB9AALDH1A1
SCHEMBL15651057 0.80 ALDH1A1 (0.57) ERN1KDM4EPTGS2RAB9APARP10
SCHEMBL15088224 0.80 MAPT (0.42) ERN1KDM4EPTGS2ALDH1A1DGAT1
SCHEMBL5087817 0.80 CES2 (0.45) ERN1KDM4EALDH1A1DGAT1KMT2A
SCHEMBL29957499 0.80 KDM4E (0.57) ERN1KDM4EPTGS2RAB9APARP10
SCHEMBL29954629 0.80 ERN1 (0.46) ERN1KDM4EALDH1A1TSHRKMT2A
SCHEMBL11287845 0.79 KDM4E (0.38) KDM4EPTGS2RAB9APARP10PARP3
SCHEMBL1800318 0.78 PARP10 (0.44) ERN1KDM4EPTGS2RAB9APARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4372091-A2 COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES Woolf, Tod M. (US) 2024-05-22 EP disclosed
EP-3230445-B1 COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES WOOLF TOD M (US) 2024-01-24 EP disclosed
EP-4023228-A1 GENOME EDITING OLIGONUCLEOTIDE WITHOUT PROGRAMMABLE NUCLEASES Woolf, Tod M. (US) 2022-07-06 EP disclosed
US-20210395729-A1 Compositions and methods for Editing Nucleic Acids in Cells Utilizing Oligonucleotides ETAGEN PHARMA, INC. 2021-12-23 US disclosed
US-20190300872-A1 Improved Methods of Genome Editing with and without Programmable Nucleases WOOLF TOD M (US) 2019-10-03 US disclosed
EP-3230445-A2 COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES Woolf, Tod M. (US) 2017-10-18 EP disclosed
WO-2016094845-A2 COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES WOOLF TOD M (US) 2016-06-16 WO disclosed